跳至主要内容
临床试验/NCT03885973
NCT03885973已完成2 期

Lactobacillus Plantarum IS 10560 Supplementation in Women With Functional Constipation: Molecular Profile of Fecal Microbiome With NGS Method

Fakultas Kedokteran Universitas Indonesia1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2018年7月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
76
试验地点
1
主要终点
Short Chain Fatty Acid (SCFA) titer

研究概览

简要总结

In this study, the investigators measured the SCFA (Butyrate, Acetate and Propionate) as a Biomarker improvement symptom and quality of life women with functional constipation after supplementation of commensal bacterial fermented milk Lactobacillus plantarum (isolated from indigenous probiotics from Dadih, West Sumatra) for 21 days

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Being declared healthy based on initial examination and the Structured Interview Questionnaire (SIQ)
  • Having the symptoms and signs of functional constipation refer to ROME IV
  • Able to communicate well
  • Able to consume 1 bottle of fermented milk each day for three weeks
  • Not using antibiotic no later than one week before supplementation

排除标准

  • Diagnosed with functional bowel disorder
  • Using anesthesia at least 4 weeks before treatment
  • Having a serious pathological disorder (carcinoma)
  • During healing phase of acute gastrointestinal disorders at least 4 weeks before treatment
  • Having severe heart disease
  • Taking chronic medications such as antidepressants or analgesics

研究组 & 干预措施

Lactobacillus plantarum

Experimental

1 bottle of fermented milk (100 g) containing probiotic Lactobacillus plantarum IS-10506 1.0x10^8 CFU will be given daily for three weeks.

干预措施: Lactobacillus plantarum (Drug)

Placebo

Placebo Comparator

1 bottle of fermented milk (100 g) containing placebo will be given daily for three weeks.

干预措施: Placebo (Drug)

结局指标

主要结局

Short Chain Fatty Acid (SCFA) titer

时间窗: Three weeks after intervention

Short Chain Fatty Acid (SCFA) titer that will be analyzed by Gas chromatography-mass spectrometry (GCMS) consists of three metabolites: * Butyrate will be shown in mM unit measure, higher value represents better outcome * Acetate will be shown in mM unit measure, higher value represents better outcome * Proprionate will be shown in mM unit measure, higher value represents better outcome

Functional constipation symptom improvement (1)

时间窗: Three weeks after intervention

Functional constipation symptom improvement (1) will be measured by improvement of PAC Sym questionnaire score. PAC Sym (Patient Assessment of Constipation Symptoms) has a minimum score of 0, maximum score 48, lower value represents better outcome

Molecular Profile of Fecal Microbiome

时间窗: Three weeks after intervention

Microbiome profile from faecal samples will be analyzed with NGS (Next Gen Sequencing) method. The result will be analyzed with MiSEq Reporter software (MSR) and will be presented in nM unit measure.

Functional constipation symptom improvement (2)

时间窗: Three weeks after intervention

Functional constipation symptom improvement (2) will be measured by improvement of PAC QoL questionnaire score. PAC QoL (Patient Assessment of Constipation Quality of Life) has a minimum score of -20, maximum score 92, lower value represents better outcome

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Murdani Abdullah

Clinical Professor

Fakultas Kedokteran Universitas Indonesia

研究点 (1)

Loading locations...

相似试验